These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 16769651

  • 1. Cytokines in idiopathic inflammatory myopathies.
    Salomonsson S, Lundberg IE.
    Autoimmunity; 2006 May; 39(3):177-90. PubMed ID: 16769651
    [Abstract] [Full Text] [Related]

  • 2. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B, Creus KK, De Bleecker JL.
    Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
    [Abstract] [Full Text] [Related]

  • 3. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?
    Loell I, Lundberg IE.
    J Intern Med; 2011 Mar; 269(3):243-57. PubMed ID: 21205023
    [Abstract] [Full Text] [Related]

  • 4. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
    Lundberg I, Kratz AK, Alexanderson H, Patarroyo M.
    Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
    [Abstract] [Full Text] [Related]

  • 5. Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.
    Megens-de Letter MA, Visser LH, van Doorn PA, Savelkoul HF.
    Eur Cytokine Netw; 1999 Dec; 10(4):471-8. PubMed ID: 10586113
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
    de Padilla CM, Reed AM.
    Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
    [Abstract] [Full Text] [Related]

  • 7. Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle.
    Nader GA, Lundberg IE.
    Curr Opin Rheumatol; 2009 Nov; 21(6):599-603. PubMed ID: 19726993
    [Abstract] [Full Text] [Related]

  • 8. Advances in the therapy of idiopathic inflammatory myopathies.
    Baer AN.
    Curr Opin Rheumatol; 2006 May; 18(3):236-41. PubMed ID: 16582685
    [Abstract] [Full Text] [Related]

  • 9. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE.
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [Abstract] [Full Text] [Related]

  • 10. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.
    Figarella-Branger D, Civatte M, Bartoli C, Pellissier JF.
    Muscle Nerve; 2003 Dec; 28(6):659-82. PubMed ID: 14639580
    [Abstract] [Full Text] [Related]

  • 11. Update on idiopathic inflammatory myopathies.
    Briani C, Doria A, Sarzi-Puttini P, Dalakas MC.
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [Abstract] [Full Text] [Related]

  • 12. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.
    De Paepe B, Creus KK, De Bleecker JL.
    Ann N Y Acad Sci; 2007 Aug; 1109():441-53. PubMed ID: 17785333
    [Abstract] [Full Text] [Related]

  • 13. The physiology of inflammatory myopathies: an overview.
    Lundberg IE.
    Acta Physiol Scand; 2001 Mar; 171(3):207-13. PubMed ID: 11412132
    [Abstract] [Full Text] [Related]

  • 14. Beta-chemokine receptor expression in idiopathic inflammatory myopathies.
    De Paepe B, De Bleecker JL.
    Muscle Nerve; 2005 May; 31(5):621-7. PubMed ID: 15772970
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications.
    Efthimiou P.
    Semin Arthritis Rheum; 2006 Dec; 36(3):168-72. PubMed ID: 16970978
    [Abstract] [Full Text] [Related]

  • 16. Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis.
    Chevrel G, Page G, Miossec P.
    Autoimmunity; 2006 May; 39(3):171-6. PubMed ID: 16769650
    [Abstract] [Full Text] [Related]

  • 17. Immunopathogenic pathways in canine inflammatory myopathies resemble human myositis.
    Shelton GD, Hoffman EP, Ghimbovschi S, Peters IR, Day MJ, Mullins M, Moore PF, Nagaraju K.
    Vet Immunol Immunopathol; 2006 Sep 15; 113(1-2):200-14. PubMed ID: 16797723
    [Abstract] [Full Text] [Related]

  • 18. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction.
    Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, Chang J, Dwivedi S, Mitsak M, Chen YW, Plotz P, Rosen A, Hoffman E, Raben N.
    Arthritis Rheum; 2005 Jun 15; 52(6):1824-35. PubMed ID: 15934115
    [Abstract] [Full Text] [Related]

  • 19. Chemokines and dendritic cells in inflammatory myopathies.
    Tournadre A, Miossec P.
    Ann Rheum Dis; 2009 Mar 15; 68(3):300-4. PubMed ID: 19213746
    [Abstract] [Full Text] [Related]

  • 20. An update on pathogenic mechanisms of inflammatory myopathies.
    Rayavarapu S, Coley W, Nagaraju K.
    Curr Opin Rheumatol; 2011 Nov 15; 23(6):579-84. PubMed ID: 21960036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.